Apexigen, Inc. Deferred Tax Assets, Valuation Allowance
Apexigen, Inc. had Deferred Tax Assets, Valuation Allowance of $44.51 million as of 2022-12-31, per its 10-K filed 2023-02-22.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2023-02-22
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $44.51M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $32.39M; Deferred Tax Assets, Valuation Allowance as first filed $124.50K.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2022-12-31 | $44.51M 10-K · filed 2023-02-22 | |
| 2021-12-31 | $32.39M 10-K · filed 2023-02-22 | $124.50K 10-K · filed 2022-04-07 |